Kenya recalls J&J children's cough syrup over suspected toxicity

12 April 2024 - 09:30 By Hereward Holland
subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now
Kenya's Pharmacy and Poisons Board (PPB) said in a statement it had commenced investigations and advised that sales of certain batches of the product be halted and returned to suppliers.
Kenya's Pharmacy and Poisons Board (PPB) said in a statement it had commenced investigations and advised that sales of certain batches of the product be halted and returned to suppliers.
Image: 123rf

Kenya's drug regulator is recalling a batch of Johnson & Johnson children's cough syrup, it said on Thursday, a day after Nigeria recalled the same batch of medication under the Benylin Paediatric brand.

Nigeria's health regulator said laboratory tests on the syrup showed a high level of diethylene glycol, which has been linked to the deaths of dozens of children in Gambia, Uzbekistan and Cameroon since 2022 in one of the world's worst waves of poisoning from oral medication.

Kenya's Pharmacy and Poisons Board (PPB) said in a statement it had commenced investigations and advised that sales of certain batches of the product be halted and returned to suppliers.

Kenvue, which now owns the Benylin brand after a spin-off from J&J last year, did not immediately respond to a request for comment.

The batch being recalled was made by J&J in South Africa in May 2021 with an expiration date of April 2024, PPD said.

Reuters


subscribe Just R20 for the first month. Support independent journalism by subscribing to our digital news package.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.